Zitter Health Insights Access Answered.

Managed Care Biologics & Injectables Index

The Managed Care Biologics and Injectables Index is the largest and longest running quantitative assessment of managed care market dynamics affecting biologic and injectable therapies.

The Index is conducted twice annually and surveys top payer decision makers (and physicians in select therapeutic categories) to explore a wide range of managed care trends and issues including physician reimbursement, prior authorization, patient cost-sharing, specialty pharmacy, biosimilars, cross-benefit management, innovative contracting, co-pay assistance, and category-specific market dynamics and trends. The Index conducts research twice annually among 100 top payer decision makers and 50 physicians each in select therapeutic categories.

What actions can you take?

  • Inform strategic decisions related to access and reimbursement of specialty pharmacy agents
  • Leverage information collectively requested by marketers from major biologics companies to develop timely managed care marketing strategies with payer research reports that evolve based on your needs
  • Make recommendations with robust, market-representative, quantitative research and analysis on managed care biologics trends
  • Improve biologic and injectable product marketing effectiveness and efficiency by staying up to date on key trends impacting specialty management and your brand
  • Optimize marketing spend based on detailed understanding of payer policies toward major biologics categories
  • Enhance payer marketing impact through reliable data on current and future biologics and injectables management

What insights are provided?

  • Longitudinal data on all major access drivers impacting specialty products
  • Data on payers’ expectations for the future of specialty pharmacy product management
  • Physician and specialty pharmacy reimbursement contract methodology, rates and prevalence
  • Perspectives of payers and physicians on utilization management techniques and cost-sharing benefit design within specific specialty categories
  • Stakeholders’ valuations of specialty pharmacy services
  • Payer expectations of the impact of new entrants into numerous specialty pharmacy categories
  • Emerging trends such as biosimilars, innovative contracting approaches and co-pay offset program dynamics


With the Managed Care Biologics and Injectables Index, you can subscribe to a basic or live subscription.

Deliverable Standard Premium
Two semi-annual editions Check Check
Four formal presentations of findings Check
Two formal presentation of findings Check
Attendance at one follow-up web conference with survey panelists per edition Check Check
Up to three customized reports/data cuts per edition (each containing up to five unique data cuts) Check
Access to the research team for follow-up questions, data clarification, or additional insight (up to ten hours of telephonic support per edition) Check